SMILE: systems metabolomics using interpretable learning and evolution
暂无分享,去创建一个
[1] D. Butterfield,et al. Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer’s Disease , 2018, Journal of Alzheimer's disease : JAD.
[2] R. K. Ursem. Multi-objective Optimization using Evolutionary Algorithms , 2009 .
[3] Victor Ciesielski,et al. Linear genetic programming , 2008, Genetic Programming and Evolvable Machines.
[4] G. Taibi,et al. Alzheimer’s disease: amino acid levels and brain metabolic status , 2013, Neurological Sciences.
[5] A. Copani,et al. Alzheimer's disease: brain expression of a metabolic disorder? , 2010, Trends in Endocrinology & Metabolism.
[6] S. Ferreira,et al. Diet-Derived Fatty Acids, Brain Inflammation, and Mental Health , 2019, Front. Neurosci..
[7] Kwanjeera Wanichthanarak,et al. Deep metabolome: Applications of deep learning in metabolomics , 2020, Computational and structural biotechnology journal.
[8] M. Tomás,et al. Oxidative stress and the amyloid beta peptide in Alzheimer’s disease , 2017, Redox biology.
[9] Timothy J. Hohman,et al. Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study , 2020, PLoS medicine.
[10] F. Gomez-Pinilla,et al. Cerebral Fructose Metabolism as a Potential Mechanism Driving Alzheimer’s Disease , 2020, Frontiers in Aging Neuroscience.
[11] Lars M Blank,et al. Machine Learning Applications for Mass Spectrometry-Based Metabolomics , 2020, Metabolites.
[12] M. Hallett,et al. Imaging Neuroinflammation in Alzheimer's Disease with Radiolabeled Arachidonic Acid and PET , 2008, Journal of Nuclear Medicine.
[13] Chandan Singh,et al. Definitions, methods, and applications in interpretable machine learning , 2019, Proceedings of the National Academy of Sciences.
[14] Ting Hu,et al. An evolutionary learning and network approach to identifying key metabolites for osteoarthritis , 2018, PLoS Comput. Biol..
[15] Yue Huang,et al. Metabolomics: a novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer’s disease , 2012, Neuroscience Bulletin.
[16] W. Xu,et al. Plasma metabolite profiles of Alzheimer's disease and mild cognitive impairment. , 2014, Journal of proteome research.
[17] A. Goate,et al. Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene. , 1998, Human molecular genetics.
[18] Christian Biemann,et al. What do we need to build explainable AI systems for the medical domain? , 2017, ArXiv.
[19] M. Čuperlović-Culf,et al. Recent advances from metabolomics and lipidomics application in alzheimer’s disease inspiring drug discovery , 2020, Expert opinion on drug discovery.
[20] C. Savage,et al. Left lateralized cerebral glucose metabolism declines in amyloid-β positive persons with mild cognitive impairment , 2018, NeuroImage: Clinical.
[21] Ting Hu,et al. Can Genetic Programming Perform Explainable Machine Learning for Bioinformatics? , 2019, GPTP.
[22] P. Dodd,et al. Glutamate–glutamine cycling in Alzheimer's disease , 2007, Neurochemistry International.
[23] M. M. Gromiha,et al. Neurodegenerative Diseases – Is Metabolic Deficiency the Root Cause? , 2020, Frontiers in Neuroscience.
[24] Riccardo Poli,et al. A Field Guide to Genetic Programming , 2008 .
[25] Strasbourg,et al. Arachidonic acid in Alzheimer's disease , 2016 .
[26] L. Schneider,et al. Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial , 2020, EBioMedicine.
[27] Miroslava Cuperlovic-Culf,et al. Machine Learning Methods for Analysis of Metabolic Data and Metabolic Pathway Modeling , 2018, Metabolites.
[28] D. Allan Butterfield,et al. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease , 2019, Nature Reviews Neuroscience.
[29] Thomas Lengauer,et al. Classification with correlated features: unreliability of feature ranking and solutions , 2011, Bioinform..
[30] Carlo Caltagirone,et al. Plasma fatty acid lipidomics in amnestic mild cognitive impairment and Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.
[31] Steven E. Arnold,et al. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums , 2018, Nature Reviews Neurology.
[32] Xianlin Han,et al. Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers , 2018, Alzheimer's & Dementia.
[33] Ting Hu,et al. Computational Methods for the Discovery of Metabolic Markers of Complex Traits , 2019, Metabolites.
[34] Y. Tseng,et al. Effects of sarcosine and N, N-dimethylglycine on NMDA receptor-mediated excitatory field potentials , 2017, Journal of Biomedical Science.
[35] Gaël Varoquaux,et al. Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..